CHE Chemed Corporation

Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

Chemed Corporation (NYSE: CHE) – Today Chemed Corporation’s Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role.

Mr. Witzeman is currently Chemed’s Vice President and Controller and serves as Chemed’s principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation () operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

EN
18/12/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chemed Corporation

 PRESS RELEASE

Chemed Corporation Announces a Five-Year $450 Million Amended and Rest...

Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CINCINNATI, April 13, 2026 (GLOBE NEWSWIRE) -- (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility (“Credit Agreement”). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner for this transaction. Bank of America, N.A., was Joint Lead Arranger, Joint Bookrunner and Syndication Agent and PNC N.A. and U.S. Bank N.A. were Co-Documentation Agents. Terms of the Credit Agreement consist of a five...

 PRESS RELEASE

Chemed To Report First Quarter 2026 Earnings April 23, Related Confere...

Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24 CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2026, on Thursday, April 23, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, April 24, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call thr...

 PRESS RELEASE

Roto-Rooter Completes Acquisitions for Two Significant Territories

Roto-Rooter Completes Acquisitions for Two Significant Territories CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- On March 31, , a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: ) announced it has purchased the territory and assets of the franchises operating in San Francisco, California and Fort Worth, Texas in two separate transactions. The aggregated, combined purchase price of these transactions was approximately $20.6 million. Collectively, these Roto-Rooter locations serve a population of approximately 3.3 million people. This purchase is part of Roto-Rooter’s ong...

Chemed Corp: 1 director

A director at Chemed Corp sold 1,500 shares at 369.370USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcar...

Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch